Who We Are
Meet The Skin Cancer Foundation
Since 1979, The Skin Cancer Foundation has made tremendous strides in helping people understand the importance of skin cancer prevention, early detection and prompt, effective treatment. We couldn’t do it without the collaboration and dedication of many talented individuals and entities, including:
- Our staff, who care deeply about our mission and work tirelessly to make a difference.
- Our officers and directors, who help us uphold the highest standards.
- Our physician members, who provide their support and expertise.
- Our corporate partners and sponsors, who make our projects and campaigns possible.
- The millions of people who use our educational information to spread the word about skin cancer.
- The donors who make our work possible.
Board of Directors
Deborah S. Sarnoff, MD
President
Clinical professor of dermatology, Ronald O. Perelman Department of Dermatology, NYU School of Medicine
Perry Robins, MD
Chairman of the Board
Professor emeritus, Ronald O. Perelman Department of Dermatology, NYU School of Medicine
Rex A. Amonette, MD
Senior Vice President
Physician emeritus, Memphis Dermatology Clinic
Elizabeth Robins, Esq.
Secretary
Bennett I. Weiner, Esq.
General Counsel
Law offices of Bennett I. Weiner
Officers
Mark A. Corrado, CPA
Treasurer
Corrado Financial Group
Elizabeth K. Hale, MD
Senior Vice President
CompleteSkinMD, clinical associate professor of Dermatology, NYU Langone Medical Center
C. William Hanke, MD
Senior Vice President
Mohs surgeon, Laser & Skin Surgery Center in Indianapolis
Ronald L. Moy, MD
Senior Vice President
Moy-Fincher-Chipps, Facial Plastics & Dermatology
Maritza I. Perez, MD
Senior Vice President
Advanced Aesthetics
Leonard H. Goldberg, MD
Vice President
Professor of clinical medicine, Houston Methodist Institute for Academic Medicine
Allan C. Halpern, MD
Vice President
Chief, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City
Medical Editors
Medical content produced by The Skin Cancer Foundation is reviewed by one or more physicians, most of whom are dermatologists specializing in skin cancer. Beyond the three listed below, additional medical editors vary based on the article, blog, newsletter, brochure or project and are too numerous to list here. But we thank all those dedicated doctors who have reviewed content for us for their time, expertise and support.
Allan C. Halpern, MD
Co-editor, The Melanoma Letter
Chief, Dermatology Service, Memorial Sloan Kettering Cancer Center, New York City
Ashfaq A. Marghoob, MD
Co-editor, The Melanoma Letter
Director of Clinical Dermatology, Memorial Sloan Kettering Skin Cancer Center, Hauppauge, New York
Désirée Ratner, MD
Editor-in-chief, Carcinomas & Keratoses
Clinical Professor, Department of Dermatology, NYU
Photobiology Committee
Scientific data for each product submitted for The Foundation’s Seal of Recommendation is rigorously reviewed by a volunteer committee of photobiologists – experts in the study of the interaction of ultraviolet radiation and the skin. It is their expertise and credibility in the field that make the Seal of Recommendation a trusted and valuable resource for consumers. The committee must be completely satisfied with the testing results for a product to be granted the Seal.
Chair
Steven Q. Wang, MD
Director of Dermatologic Oncology
Hoag Family Cancer Institute
Hoag Memorial Hospital Presbyterian
Newport Beach, California
Elizabeth Buzney, MD
Assistant Professor of Dermatology
Harvard Medical School, Brigham and Women’s Hospital
Boston, Massachusetts
Anna L. Chien, MD
Associate Professor of Dermatology
Johns Hopkins University School of Medicine
Baltimore, Maryland
Steven A. Nelson, MD
Assistant Professor of Dermatology
Mayo Clinic College of Medicine and Science
Scottsdale, Arizona
Elisabeth G. Richard, MD
Assistant Professor of Dermatology
Johns Hopkins University School of Medicine
Baltimore, Maryland
Jane Y. Yoo, MD
Assistant Clinical Professor of Dermatology
Icahn School of Medicine at Mount Sinai
New York, New York
Research Grants Committee
The Foundation’s Research Grants committee members dedicate their time and expertise to evaluate hundreds of proposals submitted by dermatology residents, fellows and young faculty. New committee members are chosen each year to avoid potential conflicts of interest.
Chair
David Polsky, MD, PhD
Alfred W. Kopf, M.D. Professor of Dermatologic Oncology
Ronald O. Perelman Department of Dermatology
Amonette Circle
The Amonette Circle takes a leadership role in supporting and delivering our programs to the public. This exclusive group of U.S.-based physicians are the most active and visible members of the Foundation.
Founders,
Rex A. Amonette, MD
Johnnie Amonette
Staff
EXECUTIVE DIRECTOR
Becky Kamowitz
ADMINISTRATION
Phyllis Palladino
Director of HR & Administration
Mayra Colon
Finance Administrator
DEVELOPMENT
Staci Pierson
Senior Director of Strategic Partnerships
Melissa Saul
Senior Director of Development
Stephanie Ogozalek
Program Partnerships Director
Rachel Kramer
Director of Development
Alexa Char
Program Coordinator
Melanie Hertgen
Development Coordinator
MARKETING COMMUNICATIONS
Victoria Kopec
Senior Director of Digital Strategy
Abby Ludowise
Senior Director of Marketing Communications
Alan Guan
Web Development Specialist
Paul Melia
Creative Services Director
Ali Venosa
Marketing Communications Manager
SCIENCE & EDUCATION
Julie Bain
Senior Director of Science & Education
Corporate Council
Our Corporate Council is a group of approximately 100 U.S. and international companies that have made a commitment to The Skin Cancer Foundation. Corporate Council members help support the Foundation’s work, which empowers people to take a proactive approach to daily sun protection and the early detection and treatment of skin cancer.
For 40 years, The Skin Cancer Foundation’s initiatives, leadership, education and programs have opened people’s eyes, led to change and saved lives. Skin cancer takes decades to develop, though, and cases are still on the rise. We have much work to do until we can eliminate deaths and ease suffering caused by the world’s most common cancer. Support by committed corporations can help us reach that goal — and help satisfy corporate social responsibility goals. We are proud of our Corporate Council and the many long-term, ongoing relationships we have nurtured within it, some since the program began in 1981.
English
Chinese (Simplified)
French
German
Italian
Portuguese
Spanish